Functional Stroke Mimics: Patient Characteristics, CT-Based Multimodal Imaging and Long-Term Outcome in a Comparative Cohort Study.
Functional stroke-like episodes (FSMs) are an increasingly recognised stroke mimic with demographic and clinical characteristics that differ from acute ischaemic strokes (AISs) but have unclear long-term outcomes.
We report retrospective data on consecutive patients with FSM who underwent acute perfusion-CT (PCT) admitted to Lausanne University Hospital (2003-2017). We compared them to all contemporaneous AISs undergoing PCT from the Acute-STroke-Registry-and-Analysis-of-Lausanne (ASTRAL).
Twenty-five FSMs and 3201 control-AISs were included. FSM patients were significantly younger (median 43 vs. 73 years, adjusted odds ratio (ORadj) 0.92), had a higher incidence of psychiatric disorders (ORadj 5.33/17.07), and over half had a prior history of neurological and non-neurological functional disorders. FSM patients more often presented decreased vigilance (ORadj = 9.28) and sensory deficits (ORadj = 3.87), and less visual field defects (ORadj = 0.14) and dysarthria (ORadj = 0.20). FSM patients showed no significant changes on plain-CT and PCT. Acute revascularisation rates were similar in both groups (48% vs. 43%). Follow-up at 3-months revealed significant handicap in 41% of patients, similar to the control group in propensity-score-matched analysis, and lower mortality (0% vs. 20%, padj 0.04). After a median of 9 years follow-up, FSM patients failed to functionally improve further and 55% experienced additional functional neurological events.
In this single-centre cohort of consecutive FSMs undergoing acute PCT, we identified distinctive demographic and clinical features, normal CT-based neuroimaging, but still a high thrombolysis rate. Long-term observation revealed a high rate of recurrent functional events and persistent disability, suggesting the need for more effective treatment and regular follow-up.
We report retrospective data on consecutive patients with FSM who underwent acute perfusion-CT (PCT) admitted to Lausanne University Hospital (2003-2017). We compared them to all contemporaneous AISs undergoing PCT from the Acute-STroke-Registry-and-Analysis-of-Lausanne (ASTRAL).
Twenty-five FSMs and 3201 control-AISs were included. FSM patients were significantly younger (median 43 vs. 73 years, adjusted odds ratio (ORadj) 0.92), had a higher incidence of psychiatric disorders (ORadj 5.33/17.07), and over half had a prior history of neurological and non-neurological functional disorders. FSM patients more often presented decreased vigilance (ORadj = 9.28) and sensory deficits (ORadj = 3.87), and less visual field defects (ORadj = 0.14) and dysarthria (ORadj = 0.20). FSM patients showed no significant changes on plain-CT and PCT. Acute revascularisation rates were similar in both groups (48% vs. 43%). Follow-up at 3-months revealed significant handicap in 41% of patients, similar to the control group in propensity-score-matched analysis, and lower mortality (0% vs. 20%, padj 0.04). After a median of 9 years follow-up, FSM patients failed to functionally improve further and 55% experienced additional functional neurological events.
In this single-centre cohort of consecutive FSMs undergoing acute PCT, we identified distinctive demographic and clinical features, normal CT-based neuroimaging, but still a high thrombolysis rate. Long-term observation revealed a high rate of recurrent functional events and persistent disability, suggesting the need for more effective treatment and regular follow-up.
Authors
Bastos Bastos, Strambo Strambo, Salerno Salerno, Dunet Dunet, Aybek Aybek, Michel Michel
View on Pubmed